New agents in chronic lymphocytic leukemia.
Gribben
John G
JG
Institute of Cancer, Barts and the London School of Medicine, London, UK.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols; D002986:Clinical Trials as Topic; D019254:Genes, bcl-2 / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents